December 13, 2024

New Myocarditis Guidelines Define Disease Stages

ACC consensus pathway introduces stages A through D for myocarditis classification, paralleling the established heart failure staging system cardiologists use daily.

Conexiant

December 13, 2024

Air Pollution Tied to Blood Clots in Veins

In a 17-year study of over 6,600 adults, researchers found that for every 3.6 µg/m3 increase in PM2.5 exposure, VTE risk increased by 39%, with even stronger associations observed in the first decade of follow-up.

Conexiant

December 12, 2024

Brief, Vigorous Activity May Lower CV Risk in Women: Study Findings

Conexiant

December 12, 2024

Comparing Ticagrelor and Prasugrel in ACS

In a 17,642-patient cohort study validating ISAR-REACT5's findings, prasugrel showed particular benefit in STEMI patients, with a striking 38% relative risk reduction in adverse events compared to ticagrelor, while maintaining similar bleeding risks.

Conexiant

December 11, 2024

Sex Differences in Statin-Linked Diabetes Risk

Conexiant

December 10, 2024

ASCVD Risk Elevated in Cutaneous Lupus

Conexiant

December 09, 2024

Breast Calcifications Linked to CVD Risk

Conexiant

December 09, 2024

CLEAR Trial: Evaluating Spironolactone in Post-MI Care

Conexiant

December 05, 2024

AHA: Smokeless Nicotine's CVD Risks

New data reveals smokeless oral nicotine products show lower cardiovascular risks than cigarettes but are associated with increased mortality in patients with existing heart conditions.

Conexiant